Moneycontrol PRO
UPCOMING EVENT:Attend Traders Carnival Live. 3 days 12 sessions at Rs.1599/-, exclusive for Moneycontrol Pro subscribers. Register now!
you are here: HomeNewsIndia

COVID-19 Update: India logs 29,616 new cases, 290 fatalities

The active cases now constitute 0.90 percent of the total infections, while the nationwide COVID-19 recovery rate was recorded at 97.78 percent, the highest since March 2020, the health ministry said.

September 25, 2021 / 10:36 AM IST
India crossed the grim milestone of two crore cases on May 4 and three crore on June 23. (Representative image)

India crossed the grim milestone of two crore cases on May 4 and three crore on June 23. (Representative image)

India logged 29,616 new coronavirus infections, taking the total tally of cases to 3,36,24,419, while the active cases rose by 1,280 to reach 3,01,442, according to Union Health Ministry data updated on September 24. The death toll climbed to 4,46,658 with 290 fresh fatalities, the data updated at 8 am showed.

The active cases now constitute 0.90 percent of the total infections, while the nationwide COVID-19 recovery rate was recorded at 97.78 percent, the highest since March 2020, the ministry said.

An increase of 1,280 cases has been recorded in the active COVID-19 caseload in a span of 24 hours, it said.

The daily positivity rate was recorded at 1.86 per cent, while the weekly positivity rate was 1.99 per cent. The latter has been below 3 per cent for the last 92 days, it said.

Also read | Over 71.04 lakh doses of COVID-19 vaccine administered on September 24

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

India's tally of case had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16.

It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.

India crossed the grim milestone of two crore cases on May 4 and three crore on June 23.
PTI
first published: Sep 25, 2021 10:28 am

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark